Fielmann Group AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005772206
EUR
42.10
-0.15 (-0.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

32.69 k

Shareholding (Jun 2025)

FII

0.03%

Held by 2 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 3,536 Million ()

stock-summary
P/E

38.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.73%

stock-summary
Debt Equity

0.21

stock-summary
Return on Equity

11.63%

stock-summary
Price to Book

3.69

Revenue and Profits:
Net Sales:
578 Million
(Quarterly Results - Dec 2024)
Net Profit:
27 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.06%
0%
-7.06%
6 Months
-23.87%
0%
-23.87%
1 Year
-4.97%
0%
-4.97%
2 Years
-6.61%
0%
-6.61%
3 Years
18.59%
0%
18.59%
4 Years
-23.03%
0%
-23.03%
5 Years
-40.95%
0%
-40.95%

Fielmann Group AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.28%
EBIT Growth (5y)
-14.20%
EBIT to Interest (avg)
20.80
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
1.63
Tax Ratio
28.96%
Dividend Payout Ratio
63.50%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
34.02%
ROE (avg)
18.65%

Valuation key factors

Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
4.40
EV to EBIT
37.09
EV to EBITDA
19.20
EV to Capital Employed
3.82
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
2.29%
ROCE (Latest)
10.30%
ROE (Latest)
11.63%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 22.51% vs 6.70% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 139.29% vs -0.88% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "577.90",
          "val2": "471.70",
          "chgp": "22.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "109.70",
          "val2": "71.50",
          "chgp": "53.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.50",
          "val2": "8.30",
          "chgp": "134.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.80",
          "val2": "11.20",
          "chgp": "139.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.90%",
          "val2": "55.00%",
          "chgp": "2.79%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.88% vs 12.05% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.66% vs 16.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,264.10",
          "val2": "1,970.90",
          "chgp": "14.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "457.20",
          "val2": "384.10",
          "chgp": "19.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.80",
          "val2": "13.10",
          "chgp": "43.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-8.30",
          "chgp": "95.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "154.20",
          "val2": "127.80",
          "chgp": "20.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "107.20%",
          "val2": "95.40%",
          "chgp": "1.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary

Dec'24
Dec'23
Change(%)
Net Sales
577.90
471.70
22.51%
Operating Profit (PBDIT) excl Other Income
109.70
71.50
53.43%
Interest
19.50
8.30
134.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.80
11.20
139.29%
Operating Profit Margin (Excl OI)
82.90%
55.00%
2.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 22.51% vs 6.70% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 139.29% vs -0.88% in Dec 2023

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
2,264.10
1,970.90
14.88%
Operating Profit (PBDIT) excl Other Income
457.20
384.10
19.03%
Interest
18.80
13.10
43.51%
Exceptional Items
-0.40
-8.30
95.18%
Consolidate Net Profit
154.20
127.80
20.66%
Operating Profit Margin (Excl OI)
107.20%
95.40%
1.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 14.88% vs 12.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 20.66% vs 16.50% in Dec 2023

stock-summaryCompany CV
About Fielmann Group AG stock-summary
stock-summary
Fielmann Group AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available